OBM Integrative and Complementary Medicine is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. It covers all evidence-based scientific studies on integrative, alternative and complementary approaches to improving health and wellness.

Topics contain but are not limited to:

  • Acupuncture
  • Acupressure
  • Acupotomy
  • Bioelectromagnetics applications
  • Pharmacological and biological treatments including their efficacy and safety
  • Diet, nutrition and lifestyle changes
  • Herbal medicine
  • Homeopathy
  • Manual healing methods (e.g., massage, physical therapy)
  • Kinesiology
  • Mind/body interventions
  • Preventive medicine
  • Research in integrative medicine
  • Education in integrative medicine
  • Related policies

It publishes a variety of article types: original research, review, communication, opinion, case report, study protocol, comment, conference report, technical note, book review, etc.

There is no restriction on paper length, provided that the text is concise and comprehensive. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility. 

Indexing: DOAJ-Directory of Open Access Journals.

Archiving: full-text archived in CLOCKSS.

Rapid publication: manuscripts are undertaken in 6.1 days from acceptance to publication (median values for papers published in this journal in the first half of 2020, 1-2 days of FREE language polishing time is also included in this period). A first decision provided to authors of manuscripts submitted to this journal are approximately 3.5 weeks (median values) after submission.

Current Issue: 2020  Archive: 2019 2018 2017 2016

Special Issue

Complementary, Traditional, and Integrative Medicine for COVID-19

Submission Deadline: December 31, 2020 (Open) Submit Now

Guest Editors

Sok Cheon Pak, PhD

School of Biomedical Sciences, Charles Sturt University, Panorama Avenue, BATHURST NSW 2795, Australia

Website | E-Mail

Interests: Honeybee venom; Evidence-based practice; Signaling pathway; Integrative therapeutics

Soo Liang Ooi

School of Biomedical Sciences, Charles Sturt University, Panorama Avenue, BATHURST NSW 2795, Australia

Website | E-Mail

Interests: Complementary therapies; Nutrition; Naturopathy; Microbiome

About this topic

Dear Colleagues,

SARS-CoV-2 is spreading over the world with no country spared from its infections. COVID-19 is the disease caused by this novel coronavirus, and it has already claimed over 120,000 lives with close to 2 million confirmed cases as of 15 April 2020. Sadly, the numbers are still rising fast each day with no sign of slowing down. This pandemic is expected to last for months to come with much of the world living in lockdown.

There is currently no effective treatment for COVID-19, and the earliest possibility of having a vaccine is not until early 2021. The medical world is actively trying to repurpose existing drugs and therapies to treat this disease. Among them include anti-viral agents used to treat SARS (Lopinavir-ritonavir), an experimental drug for Ebola virus (Remdesivir), and old anti-malarial mediations (Chloroquine / Hydroxychloroquine). Many clinical trials are currently in progress to validate the effectiveness of different repurposed therapies. The hunt for a cure is on-going.

Complementary, traditional, and integrative medicine can play a vital role in supporting the treatment of COVID-19. For example, many herbs possess anti-viral, anti-inflammatory, and antioxidant properties that can be extremely helpful in treating viral infections. Nutritional interventions also play a critical role in preventing and controlling the disease, especially among older patients with comorbidities. Probiotics have been suggested to be a potential adjunct treatment as some patients with COVID-19 showed gut dysbiosis with decreased Lactobacillus and Bifidobacterium. Hence, it will be a significant loss if the repertoire of non-pharmacological therapies is overlooked in the search for remedies. Yet, the dominant medical journals rarely feature the use of complementary, traditional, and integrative medicine in their COVID-19 publications.

This special issue provides an open forum for researchers to share their research findings in the use of complementary, traditional, and integrative medicine for COVID-19. We welcome contributions in any form, including letter to the editor, original research, case report, and review. Results from human clinical trials are particularly welcome.

Dr. Sokcheon Pak
Mr. Soo Liang Ooi
Guest Editors


• COVID-19
• Novel coronavirus
• Herbs
• Nutrition
• Nutraceutical

Planned Paper:

Tentative Title: Herbs and Cytokine Storm Risk in COVID-19
Author: Karry Bone
Brief Description: Concerns have been raised that certain herbs acting on the immune system might deleteriously enhance the cytokine response during acute respiratory viral infections. These concerns are not supported by a detailed analysis of the published scientific and traditional literature.